Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


S. Korea Panel Recommends Restricting Painkillers To 15 And Older

This article was originally published in PharmAsia News

Executive Summary

South Korea's drug regulator is expected to accept a recommendation that certain painkillers be restricted to persons 15 years of age and older. Among the drugs on a list drafted by the Central Pharmaceutical Affairs Council were popular medicines such as Bayer Korea's Saridon-A and Samjin Pharm's Geworin because their active pharmaceutical ingredient is isopropylantipyrine. The council said in its recommendation to the South Korea FDA the drug can cause heart disorders and loss of consciousness and should not be available to people under the age of 15. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts